Liver-specific expression of the gene coding for human factor X, a blood coagulation factor

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Factor X is a vital glycoprotein in blood coagulation.
• Understanding the regulation of factor X gene expression is critical for controlling bleeding disorders.

Purpose of the Study:

• To identify and characterize regulatory elements in the 5'-flanking region of the human factor X gene.
• To elucidate the liver-specific transcriptional control mechanisms of factor X.

Main Methods:

• Gene cloning and construction of recombinant plasmids with reporter genes (chloramphenicol acetyltransferase).
• Transient expression assays in HepG2 cells, human fibroblasts, and Chinese hamster ovary cells.
• DNase I footprinting and electrophoretic mobility shift assays (EMSA) to identify protein-DNA interactions.

Main Results:

• A 2.8-kilobase intergenic region between the factor VII and factor X genes was analyzed.
• A liver-specific promoter element (FXP1) located at -63 to -42 bp was identified, homologous to hepatic nuclear factor-4 (HNF-4) binding sites.
• Two upstream positive regulatory elements (FXP2 at -215 to -149 bp and FXP3 at -457 to -351 bp) were characterized.

Conclusions:

• The identified elements (FXP1, FXP2, FXP3) play significant roles in regulating human factor X gene transcription.
• FXP1 acts as a critical liver-specific promoter, binding nuclear proteins like HNF-4.
• These findings provide insights into the molecular mechanisms governing factor X production in hepatocytes.